Longitudinal Cortical Surface Signatures Distinguish Neuromyelitis Optica Spectrum Disorder from Multiple Sclerosis.
文献摘要
Background and purpose Neuromyelitis optica spectrum disorder (NMOSD) is a chronic condition driven by selective injury to aquaporin 4 (AQP4) channels. Accurate diagnosis and effective disease surveillance are critical to preventing permanent neurologic disability. Targeted imaging of cortical gyri and sulci was explored due to the widespread AQP4 distribution, enabling comparison with MS. Materials and methods This was a retrospective study at a single academic center involving people with NMOSD and MS, each having 2-8 MRI time points. Longitudinal cortical surface-based morphometry and conventional cortical gray matter volumes were quantified in isolated gyri and sulci. Results Sixty-two individuals were included (31 fulfilling international panel criteria for NMOSD and 31 meeting 2017 McDonald criteria for MS), yielding 113 NMOSD and 133 MS MRI studies for analysis. NMOSD subjects were older (median age: 48.8 years, range 23.2-87.5 years) compared with those with MS (median age: 42.8 years, range 30.0-57.6 years). When analyzed separately by group, individuals with NMOSD demonstrated a significant annual decrease in 3D cortical gyri volume (-0.0514 mm 3 /y; 95% CI, -0.0859 to -0.0168), whereas no significant change was observed in those with MS (0.0118 mm 3 /y; 95% CI, -0.0275 to 0.0512). Additionally, between groups, the annualized rate of 3D cortical gyri volume decrease was significantly greater in NMOSD compared with MS, with a difference of -0.0632 mm 3 /y observed (95% CI, -0.1019 to -0.0246; P = .003). No significant change in average sulci volume was observed for those with MS (0.0022 mm 3 /y; 95% CI, -0.0070 to 0.0114) or with NMOSD (-0.0062 mm 3 /y; 95% CI, -0.0155 to 0.0031), and no difference between groups was identified. Prior relapses were not associated with changes in gyral or sulcal volumes per year in NMOSD or MS. Conclusions Longitudinal reductions in distinct cortical regions may serve as an ideal metric for differentiating NMOSD from MS and may provide evidence of subclinical disease activity.